Epicrispr Biotechnologies
Develops programmable epigenetic medicines to treat genetic diseases like FSHD
$90MSeries C
Role not disclosedActivity from announced rounds
Develops programmable epigenetic medicines to treat genetic diseases like FSHD
Fabless semiconductor company building connectivity chips for hyperscale, edge, and AI data centers